Cintia Piccina, Chief Commercial Officer at Adaptimmune Therapeutics PLC (ADAP), sold 12,991 shares at $0.57 ($7K) on 2025-01-15, disclosed to the SEC on 2025-01-15.
Open-market sale of $7k ADAP by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2023-01-31 | $22K | — | Filing → |
| ADAP | SELL | 2022-08-01 | $37K | — | Filing → |